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Abstract 
HLA-DRB alleles are class II alleles that are associated with CD4+ T-cell immune response. DRB alleles are polymorphic and currently there are 
about 622 named in the IMGT/HLA sequence database. Each allele binds short peptides with high sensitivity and specificity. However, it has 
been suggested that majority of HLA alleles can be covered within few HLA supertypes, where different members of a supertype bind similar 
peptides showing distinct repertoires. Definition of DRB supertypes using binding data is limited to few (about 29) known alleles (< 5% of all 
known DRB alleles). Hence, we describe a strategy using structurally defined virtual pockets to group all known DRB alleles with regard to their 
overlapping peptide binding specificity.  
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Background: 
Class II human leukocyte antigen molecules (HLA II) are 
glycoproteins that binds to various antigenic peptides processed by 
endocytic pathway and present them to CD4+ T cells for immune 
response [1]. The antigen binding groove is made up of 2 domains (α 1 
and β 1) from α chain and β chain [2]. The amino acid residues lining 
these domains interact with antigenic peptide residues and form a 
stable HLA-II p complex which is recognized by the CD4+ T cells. 
Several autoimmune diseases (good pasture’s syndrome, type 1 
diabetes etc.) and parasitic diseases (malaria, filariasis etc.) are 
associated with CD4+ T cells involving HLA II molecules [3]. Class II 
HLA molecules are highly polymorphic and 622 DRB alleles are listed 
in IMGT/HLA database (release 2.22) [4]. The observed sequence 
polymorphism in class II is a challenge in the design of peptide based 
vaccines directed against CD4+ T cell associated diseases. An ideal 
peptide based vaccine is a cocktail of peptides with broad specificity to 
different ethnic groups. Thus, it is important to identify peptides with 
overlapping specificity to multiple alleles covering a wide range of 
ethnic diversity. It has been suggested that majority of alleles can be 
covered within few HLA supertypes, where different members of a 
supertype bind similar peptides, yet exhibiting distinct repertoires [5]. 
 
Sette and colleagues (1998) analysed DRB1*0101, DRB1*0401 and 
DRB1*0701 using a collection of 384 synthetic peptides with 
competitive binding assay data (IC50). Peptide binding data for these 
three alleles and nine other DRB alleles (DRB1*1501, DRB1*0405, 
DRB1*0802, DRB1*0901, DRB1*1101, DRB1*1201, DRB1*1302, 
DRB5*0101, DRB4*0101) were used to show overlapping peptide 
binding repertoires [6]. Maillere and colleagues (2002) described a 
new supertype for HLA DP4 alleles using DPA1*0103/DPB1*0401 
(DP401) and DPA1*0103/DPB1*0402 (DP402) binding assay data 
(considering IC50 values for binding affinity) of various peptides 
derived from allergens, viruses, or tumor antigens [7]. Sette and 
colleagues (2002) showed that HLA-DQA1*0501/B*0201 (DQ2.3) 
and DQA1*0301/B*0302 (DQ3.2) share large overlapping peptide 
binding functions (using IC50 values for binding affinity) [8]. They 
also showed the cross reactivity of DR restricted epitopes with DQ 
alleles. Thus, a significant amount of functional overlap is observed 
using peptide binding assay data between different class II alleles in 
multiple layers. The number of class II alleles known and defined till 
is more than 1000. Therefore, it is important to establish theoretical 
methods to group alleles exhibiting peptide binding functional overlap. 
 
Lund and colleagues (2004) developed specificity weight matrices 
using Gibbs sampling algorithm to define nine DRB supertypes [9]. 
Flower and Doytchinova (2005) clustered Class II HLA alleles into 
twelve supertypes (five DR, three DQ and four DP) based on 
hierarchical (using similarity field generated by CoMSIA) and non 
hierarchical (k-means) clustering [10]. Clustering of MHC peptide-
binding repertoires was utilized elsewhere for supertype definition by 
Reche & Reinherz (2007) [11]. These results provide frameworks for 
understanding class II supertypes. The current update for class II 
alleles is 1000 at IMGT/HLA. Therefore, it is important to develop 
novel methods to group class II alleles with overlapping peptide 
binding function. Here, we describe a method based on virtual pockets 
defined from structural data to group HLA DRB alleles with 
overlapping peptide binding repertoires. We chose DRB alleles which 




DRB specific peptides from MHCBN database: 
We retrieved 1580 DRB specific immunogenic (CD4+ cytotoxicity) 
peptides from MHCBN, a database of MHC binders and non-binders 
[12]. We then created a subset data of 1064 DRB specific peptides that 
are documented to bind DRB alleles defined using sequence based 
nomenclature. This corresponds to 37 DRB alleles. It should be noted 
that this subset of DRB specific peptides have both binding specificity 
and CD4+ cytotoxicity. The remaining 516 DRB specific peptides are 
documented to bind DRB alleles defined using serological methods 
without sequence level specificity. Hence, this subset is neglected in 
further analysis. 
  
DRB supertypes in MHCBN dataset: 
The dataset consisting of 1064 DRB specific peptides were further 
analyzed to identify functional peptide binding overlap between 
alleles. This exercise identified 145 peptides binding to two or more 
DRB alleles, thus exhibiting peptide binding functional overlap (Table 
1 in supplementary material). The 145 peptides cover 29 DRB alleles. 
The grouping of DRB supertypes in MHCBN is illustrated in Figure 
1. 
 
DRB allele specific sequences from IMGT/HLA database: 
We downloaded 622 DRB alleles (62% of known class II alleles) from 
IMGT/HLA for further analysis. 
 
Peptide binding domain: 
The peptide binding groove is formed by two domains each from alpha 
and beta chains (Figure 2). The β1 domain (first 90 residues in the N 
terminal) from beta chain that constitutes the peptide binding groove is 
considered for further analysis. Bioinformation   open access 
www.bioinformation.net    Hypothesis
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Figure 1: The grouping of DRB supertypes in MHCBN is illustrated. 
 
 
Figure 2: The peptide binding groove is formed by two domains each from alpha and beta chainsBioinformation   open access 
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Figure 3: The workflow for the identification of DRB alleles in IMGT/HLA with overlapping function is given. Bioinformation   open access 
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Figure 4: The workflow for the grouping DRB alleles is shown. 
 
Virtual pockets in DRB molecules: 
The peptide binds with the DRB molecules through peptide residue 
position specific interactions with the pockets in the groove. These 
virtual binding pockets accommodate the side chains of amino acid 
residues of antigenic peptides. Mohanapriya and colleagues (2009) 
defined nine virtual pockets using 15 non-redundant class II HLA-
peptide crystal structures [13]. The HLA amino acid residues lying in 
these virtual binding pockets show polymorphism which determines 
the specificity and sensitivity. These residue positions forming the 
virtual pockets are called highly essential residue positions (HERP) as 
defined elsewhere by Mohanapriya and colleagues (2009) [13]. The 
number of HERP defined for the beta chain of class II molecules is 
twenty-five. 
 
Grouping of HLA DRB alleles for overlapping peptide binding: 
We extracted the residues corresponding to the 25 HERP in 622 DRB 
alleles in IMGT/HLA. The sequence stretch formed by the 
discontinuous HERP in 622 DRB alleles was compared among 
themselves to cluster those having similar sequence stretch. Thus, we 
obtained 395 groups by this procedure such that alleles within the 
same group share the HERP sequence stretch. This procedure 
generated 73 groups (Table 2 in supplementary material) containing 
two or more alleles and 322 groups with only one allele. The 
hypothesis is that alleles within the group show functional overlap 
thereby exhibiting potential supertypes. It should be noted that alleles 
in 322 groups do not share HERP sequence stretch among them. The 
workflow for the identification of DRB alleles in IMGT/HLA with 
overlapping function is given in Figure 3 and the grouping is shown in 
Figure 4. 
 
Validation of grouping for HLA DRB alleles: 
Table 3 shows 32 peptides (retrieved from MHCBN) binding to 
DRB1*1101 and DRB1 *1104 with CD4+ cyto-toxicity. Table 2 (see 
supplementary material) shows that these two alleles (DRB1*1101 and 
DRB1 *1104) fall under the same category. Table 3 (see 
supplementary material) also shows 6 peptides (retrieved from 
MHCBN) binding to DRB1*1301 and DRB1*1302 with CD4+ cyto-
toxicity. Table 2 (see supplementary material) shows that these two 
alleles (DRB1*1301 and DRB1*1302) fall under the same category. 
Thus, peptide data in Table 3 (see supplementary material) validates 




HLA-DRB alleles are associated with CD4+ T-cell immune response. 
DRB alleles are polymorphic (sequence level variation) in the 
population and about 622 DRB alleles are named in IMGT/HLA 
sequence database till date. Each of these alleles bind short peptide 
antigens with high sensitivity and specificity for CD4+ T-cell immune 
response. However, it has been suggested that majority of alleles can 
be covered within few HLA supertypes, where different members of a 
supertype bind similar peptides, yet exhibiting distinct repertoires [6]. 
The binding of peptides to HLA alleles is usually assessed using 
competitive binding assay in IC50 values. Thus, supertypes are defined 
using peptide binding IC50 values known for two or more alleles. Sette 
and colleagues (1998) analysed DRB1*0101, DRB1*0401 and 
DRB1*0701 using a collection of 384 synthetic peptides with 
competitive binding assay data (IC50). Peptide binding data for these 
three alleles and nine other DRB alleles (DRB1*1501, DRB1*0405, 
DRB1*0802, DRB1*0901, DRB1*1101, DRB1*1201, DRB1*1302, 
DRB5*0101, DRB4*0101) were used to show overlapping peptide 
binding repertoires [6]. However, this study accounts for just 12 
alleles, which is far less than the number of known 622 alleles. Flower 
and Doytchinova (2005) clustered 347 DRB alleles into five DR 
supertypes based on hierarchical (using similarity field generated by 
CoMSIA) and non hierarchical (k-means) clustering [10]. We use the Bioinformation   open access 
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ISSN  0973-2063 (online) 0973-8894 (print)     
Bioinformation 4(7): 300-309 (2010)    © 2010 Biomedical Informatics
 
304
IC50 values known for two or more alleles that are made available at 
the MHCBN database (database of allele specific binders and non-
binders). We extracted 1064 HLA-DRB (sequence based definition) 
specific peptides from MHCBN. 145 peptides in the dataset are found 
to bind more than one allele covering 29 alleles. These alleles exhibit 
supertype like function. This accounts for only 4.6% of known 622 
DRB alleles till date. Therefore, it is important to develop framework 
charts to group defined DRB alleles into potential supertypes with 
overlapping peptide binding function. Here, we define a methodology 
for grouping DRB alleles from sequence data using virtual pockets. 
 
The binding groove in DRB molecules is formed by alpha and beta 
chains (Figure 2). It accommodates peptides of length 12-35 [13]. The 
peptides bound to the groove have an extended conformation in class 
II unlike class I. The sequence similarity between defined class II 
alleles is more than 70% and hence their structural similarity is high 
(Figure 5). The receptor backbone is highly similar and only their 
side-chain orientations vary. Therefore, the peptide binding specificity 
is determined by the side chains influenced by polymorphism of the 
MHC alleles. Mohanapriya and colleagues (2009) defined virtual 
pockets using HERP extracted from HLA-peptide structural 
complexes [13]. The hypothesis is that the 25 residues at the HERP 
forming the virtual pockets are deterministic of peptide binding and its 
specificity. The high degree of sequence homology between known 
DRB alleles and hence their structural similarity suggests the influence 
of polymorphic residues at the virtual pockets to determine peptide 
specificity (Figure 6). We thus theoretically grouped the known 622 
DRB alleles using virtual pockets defined from structural datasets. The 
grouping (Figure 4) using the procedure illustrated in Figure 3 
produced 73 groups consisting of at least 2 alleles covering about 300 
alleles. Thus, the 73 groups exhibit overlapping peptide binding 
function. This grouping is validated using known peptides (32 peptides 
bind to DRB1*1101 and DRB1 *1104 and 6 peptides bind to 
DRB1*1301 and DRB1*1302) that are clustered within the same 
groups in this study. The data presented here serves in general as a 
framework for understanding peptide binding overlap in particular for 
HLA-DRB supertype definition and groupings.  Each DRB allele 
contains nine virtual pockets by definition. Thus, the 622 DRB alleles 
theoretically contain a pool of 5598 virtual pockets made of HERP 
residues in the dataset. The current analysis shows that the 622 DRB 
alleles accounts for only 569 unique pockets (Figure 7). This 
constitutes only about 10% of theoretically possible virtual pockets 
suggesting overlap of virtual pockets among 90% of the remaining 
pocket combinations. Thus, the study demonstrates the possible degree 
of overlap within virtual pockets for potential functional overlap 
among DRB alleles. The described framework finds application in the 
design of epitopes with cross reactivity across DRB specific ethnic 
population towards peptide vaccine development. 
   
 
Figure 5: The sequence similarity between defined class II alleles is more than 70% and hence their structural similarity is high.  
 
 
Figure 6: The high degree of sequence homology between known DRB alleles and hence their structural similarity suggests the influence of 
polymorphic residues at the virtual pockets to determine peptide specificity. The average virtual pockets are generated using a dataset of 15 
structures described elsewhere [13]. Bioinformation   open access 
www.bioinformation.net    Hypothesis
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Figure 7: Grouping showing that the 622 DRB alleles accounts for 569 unique pockets  
 
Conclusion: 
HLA DRB alleles are associated with CD4+ T-cell immune response 
and relevant diseases. Design of vaccine candidates with cross 
reactivity across DRB specific ethnic population requires a 
consideration of peptide binding functional overlap among DRB 
alleles. We grouped the known 622 DRB alleles using virtual pockets 
defined from structural datasets. The grouping produced 73 groups 
consisting of at least 2 alleles covering about 300 alleles. Thus, the 73 
groups exhibit overlapping peptide binding function. This grouping is 
validated using known peptides (32 peptides bind to DRB1*1101 and 
DRB1 *1104 and 6 peptides bind to DRB1*1301 and DRB1*1302) 
that are clustered within the same groups. The data presented here 
serves as a framework for understanding peptide binding overlap for 
HLA-DRB supertype definition and groupings. 
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Supplementary material  
 
Table 1: Class II HLA specific peptides from MHCBN with overlapping peptide binding  
Peptide alleles  DRB  alleles 
DGVNYATGNLPGCSA    19  DRB1*0102, DRB1*0301, DRB1*0302, DRB1*0401, DRB1*0402, DRB1*0701, DRB1*0802, DRB1*0901, DRB1*1101, DRB1*1102, 
DRB1*1103, DRB1*1104, DRB1*1301, DRB1*1302, DRB1*1402, DRB1*1502, DRB1*1601, DRB1*1501, DRB1*0101 
IDTLTCGFADLMGYA  18  DRB1*0102, DRB1*0301, DRB1*0302, DRB1*0401, DRB1*0402, DRB1*0701, DRB1*0802, DRB1*0901, DRB1*1101, DRB1*1102, 
DRB1*1103, DRB1*1104, DRB1*1301, DRB1*1302, DRB1*1402, DRB1*1502, DRB1*1501, DRB1*0101 
NLGKVIDTLTCGFA  17  DRB1*0102, DRB1*0301, DRB1*0401, DRB1*0402, DRB1*0701, DRB1*0802, DRB1*0901, DRB1*1101, DRB1*1102, DRB1*1103, 
DRB1*1104, DRB1*1301, DRB1*1302, DRB1*1402, DRB1*1502, DRB1*1501, DRB1*0101 
TCGFADLMGYIPLVA  17  DRB1*0102, DRB1*0301, DRB1*0401, DRB1*0402, DRB1*0701, DRB1*0802, DRB1*0901, DRB1*1101, DRB1*1102, DRB1*1103, 





DRB1*0102, DRB1*0402, DRB1*0701, DRB1*0802, DRB1*0901, DRB1*1101, DRB1*1102, DRB1*1103, DRB1*1104, DRB1*1402, 





DRB1*0102, DRB1*0402, DRB1*0802, DRB1*0901, DRB1*1101, DRB1*1102, DRB1*1103, DRB1*1301, DRB1*1302, DRB1*1502, 































DRB1*0102, DRB1*0401, DRB1*0402, DRB1*1101, DRB1*1102, DRB1*1104, DRB1*1301, DRB1*1302, DRB1*1601, DRB1*1501, 
DRB1*0101 
GAARALAHGVRVLEA   10 
 
DRB1*0102, DRB1*0402, DRB1*0701, DRB1*0901, DRB1*1101, DRB1*1103, DRB1*1302, DRB1*1402, DRB1*1502, DRB1*1501 
GWLLSPRGSRPSWGA 10 
 
DRB1*0102, DRB1*0302, DRB1*0401, DRB1*0402, DRB1*0802, DRB1*1101, DRB1*1104, DRB1*1302, DRB1*1402, DRB1*1501 
KYKIAGGIAGGLALL 10 
 
DRB1*0401, DRB1*0405, DRB1*1101, DRB1*1201, DRB1*1302, DRB1*0701, DRB1*0802, DRB1*0901, DRB1*0101, DRB5*0101 
SSVFNVVNSSIGLIM   10 
 
DRB1*0401, DRB1*0405, DRB1*1101, DRB1*1302, DRB1*0701, DRB1*0802, DRB1*0901, DRB1*1501, DRB1*0101, DRB5*0101 
GAPLGGAARALAHGA  9  DRB1*0102, DRB1*0402, DRB1*0802, DRB1*1101, DRB1*1104, DRB1*1302, DRB1*1402, DRB1*1501, DRB1*1502 
MNYYGKQEENWYSLKK  9  DRB1*0401, DRB1*0405, DRB1*1101, DRB1*1302, DRB1*0701, DRB1*0802, DRB1*0901, DRB1*0101, DRB5*0101 
VKNVIGPMKAVCVE  9  DRB1*1101, DRB1*1201, DRB4*0101, DRB1*1302, DRB1*0701, DRB1*0802, DRB1*0901, DRB1*0101, DRB5*0101 
MRKLAILSVSSFLFV  8  DRB1*0401, DRB1*0405, DRB1*1101, DRB1*1302, DRB1*0701, DRB1*0901, DRB1*0101, DRB5*0101 
AGLLLGNVSTVLLGGV  7  DRB1*0401, DRB1*0405, DRB1*1302, DRB1*0701, DRB1*0901, DRB1*0101, DRB5*0101 
RDRIGDNELEERIIYPGT 7  DRB1*1101,  DRB1*1301, DRB1*0301, DRB1*0401, DRB1*0701, DRB1*1501, DRB1*0101 
TASHTRLSCDCDDKFYDC   7  DRB1*1101, DRB1*1301, DRB1*0301, DRB1*0401, DRB1*0701, DRB1*1501, DRB1*0101 
TRLSCDCDDKFYD  7  DRB1*1101, DRB1*1301, DRB1*0301, DRB1*0401, DRB1*0701, DRB1*1501, DRB1*0101 
TRLSCDCDDKFYDCLKNS 7  DRB1*1101,  DRB1*1301,  DRB1*0301, DRB1*0401, DRB1*0701, DRB1*1501, DRB1*0101 
CDCDDKFYDCLKNSADTI 6  DRB1*1101,  DRB1*0301, DRB1*0401, DRB1*0701, DRB1*1501, DRB1*0101 
CPDVMSAGESKHGLTNTA 6  DRB1*1101,  DRB1*0301, DRB1*0401, DRB1*0701, DRB1*1501, DRB1*0101 
DCDDKFYDCLKNS 6  DRB1*1101,  DRB1*0301,  DRB1*0401, DRB1*0701, DRB1*1501, DRB1*0101 
DVMSAGESKHGLTNTASH 6  DRB1*1101, DRB1*0301, DRB1*0401, DRB1*0701, DRB1*1501, DRB1*0101 
GDNELEERIIYPGTLWCG 6  DRB1*1101,  DRB1*0301, DRB1*0401, DRB1*0701, DRB1*1501, DRB1*0101 
GLTNTASHTRLSCDCDDK  6  DRB1*1101, DRB1*0301, DRB1*0401, DRB1*0701, DRB1*1501, DRB1*0101 
IPLVGAPLGGAARA 6  DRB1*0102,  DRB1*0402,  DRB1*0802, DRB1*1104, DRB1*1502, DRB1*0101 
LSCDCDDKFYDCL 6  DRB1*1101,  DRB1*0401, DRB1*0701, DRB1*1501, DRB1*0301, DRB1*0101 
RLSCDCDDKFYDC 6  DRB1*1101,  DRB1*1301,  DRB1*0301, DRB1*0701, DRB1*1501, DRB1*0101 
RRGPRLGVRATRKTA 6  DRB1*0402,  DRB1*0802, DRB1*1101, DRB1*1301, DRB1*1402, DRB1*1601 
THDMCPDVMSAGESKHGL 6  DRB1*1101,  DRB1*0301, DRB1*0401, DRB1*0701, DRB1*1501, DRB1*0101 
YFVGKMYFNLIDTKCYKL  6  DRB1*1101, DRB1*1301, DRB1*0301, DRB1*0401, DRB1*0701, DRB1*1501 
ACCRTHDMCPDVMSAGES  5  DRB1*1101, DRB1*0301, DRB1*0401, DRB1*0701, DRB1*1501 
CDCDDKFYDCLKN  5  DRB1*0301, DRB1*0401, DRB1*0701, DRB1*1501, DRB1*0101 
DKFYDCLKNSADTISSYF  5  DRB1*1101, DRB1*0301, DRB1*0401, DRB1*0701, DRB1*0101 
GPNELGRFKHTDACCRTH  5  DRB1*1301, DRB1*0301, DRB1*0401, DRB1*0701, DRB1*1501 
GWQIRDRIGDNELEERII  5  DRB1*1101, DRB1*1301, DRB1*0401, DRB1*0701, DRB1*0101 
HTRLSCDCDDKFY 5  DRB1*1101,  DRB1*0301, DRB1*0401, DRB1*0701, DRB1*0101 
KMYFNLIDTKCYKLEHPV  5  DRB1*1101, DRB1*0301, DRB1*0401, DRB1*0701, DRB1*1501 
NLIDTKCYKLEHPVTGCG  5  DRB1*1101, DRB1*1301, DRB1*0401, DRB1*0701, DRB1*1501 
PGGGQIVGGVYLLPA  5  DRB1*0102, DRB1*0701, DRB1*0901, DRB1*1103, DRB1*1501 
SCDCDDKFYDCLK 5  DRB1*0301,  DRB1*0401, DRB1*0701, DRB1*1501, DRB1*0101 
SHTRLSCDCDDKF  5  DRB1*1101, DRB1*0401, DRB1*0701, DRB1*0301, DRB1*0101 
ASHTRLSCDCDDK 4  DRB1*1101,  DRB1*0401, DRB1*1501, DRB1*0101 
CDDKFYDCLKNSA  4  DRB1*1101, DRB1*0401, DRB1*0701, DRB1*0101 
DKFYDCLKNSADT  4  DRB1*1101, DRB1*0401, DRB1*0701, DRB1*0101 
GSLFLLLLSTSHGWQIRD  4  DRB1*0401, DRB1*0701, DRB1*1501, DRB1*0101 
GTLWCGHGNKSSGPNELG  4  DRB1*0301, DRB1*0401, DRB1*0701, DRB1*1501 
GYKVLVLNPSVAAT  4  DRB1*0401, DRB1*1101, DRB1*1201, DRB1*1302 
LGRFKHTDACCRTHDMCP  4  DRB1*1301, DRB1*0301, DRB1*0701, DRB1*1501 
LLLLSTSHGWQIRDRIGD  4  DRB1*0401, DRB1*0701, DRB1*1501, DRB1*0101 
LTNTASHTRLSCD  4  DRB1*1101, DRB1*0401, DRB1*0701, DRB1*1501 
QYIKANSKFIGITE  4  DRB3*0101, DRB1*1101, DRB1*1104, DRB1*1302 
RLGVRATRKTSERSA 4  DRB1*0402,  DRB1*0802, DRB1*1101, DRB1*1104 
RRRSRNLGKVIDTLA  4  DRB1*0402, DRB1*0802, DRB1*1101, DRB1*1104 
TASHTRLSCDCDD  4  DRB1*1101, DRB1*0401, DRB1*0701, DRB1*1501 
TISSYFVGKMYFNLIDTK  4  DRB1*1101, DRB1*0401, DRB1*0701, DRB1*1501 
TNTASHTRLSCDC  4  DRB1*1101, DRB1*0401, DRB1*0701, DRB1*1501 
VHFFKNIVTARTP 4  DRB1*1501,  DRB1*1302, DRB1*0401, DRB1*0402 
VHFFKNIVTPATP  4  DRB1*1501, DRB1*1302, DRB1*0401, DRB1*0402 
VHFFKNIVTPRAP 4  DRB1*1501,  DRB1*1302, DRB1*0401, DRB1*0402 
VHFFKNIVTPRTP 4  DRB1*1501,  DRB1*1302, DRB1*0402, DRB5*0101 Bioinformation   open access 
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AYIKANSKFIGITE  3  DRB1*1101, DRB1*1104, DRB1*1302 
CPKYVKQNTLKLATG  3  DRB1*1101, DRB1*1301, DRB1*0402 
CPKYVKQNTLKLATGMRNVPEKQT 3  DRB3*1101, DRB3*1103, DRB3*1104 
DDKFYDCLKNSAD  3  DRB1*1101, DRB1*0401, DRB1*0101 
GLTNTASHTRLSC  3  DRB1*1101, DRB1*0701, DRB1*1501 
IIYPGTLWCGHGNKSSGP  3  DRB1*0301, DRB1*0401, DRB1*0701 
KFYDCLKNSADTI  3  DRB1*1101, DRB1*0401, DRB1*0101 
MSAGESKHGLTNTASHTR  3  DRB1*0401, DRB1*0701, DRB1*1501 
NTASHTRLSCDCD  3  DRB1*1101, DRB1*0701, DRB1*1501 
QAIKANSKFIGITE  3  DRB1*1101, DRB1*1104, DRB1*1302 
QPRGRRQPIPKARQA  3  DRB1*0102, DRB1*0402, DRB1*0802 
QYIKANSKFAGITE  3  DRB1*1101, DRB1*1104, DRB1*1302 
QYIKANSKFIAITE  3  DRB1*1104, DRB1*1101, DRB1*1302 
QYIKANSKFIGATE  3  DRB1*1101, DRB1*1104, DRB1*1302 
QYIKANSKFIGIAE    3  DRB1*1101, DRB1*1104, DRB1*1302 
QYIKANSKFIGITA  3  DRB1*1101, DRB1*1104, DRB1*1302 
VHAFKNIVTPRTP  3  DRB1*1501, DRB1*0401, DRB1*0402 
VHFAKNIVTPRTP  3  DRB1*0401, DRB1*0402, DRB1*1501 
VHFFANIVTPRTP  3  DRB1*1302, DRB1*0401, DRB1*0402 
VHFFKNAVTPRTP  3  DRB1*1302, DRB1*0401, DRB1*0402 
VHFFKNIATPRTP  3  DRB1*1302, DRB1*0401, DRB1*0402 
AADHRQLQLSISSCLQQL 2  DRB4*0103,  DRB4*0101 
ALFNRLLDDLGF   2  DRB1*0401,  DRB1*0404 
ASDYKSAHKGFKGVD 2  DRB1*1501,  DRB5*0101 
AVSFWLRVPKVSSHLE 2  DRB1*1101,  DRB1*1104 
CGHGNKSSGPNELGRFKH 2  DRB1*0401,  DRB1*0701 
CPKAVKQNTLKLATG 2  DRB1*0402,  DRB1*1301 
CPKYVKQNALKLATG 2  DRB1*1101,  DRB1*1301 
CPKYVKQNTLKAATG 2  DRB1*1301,  DRB1*0402 
DCLKNSADTISSYFVGKM 2  DRB1*0301,  DRB1*0701 
DFEFEQMFTDAMG   2  DRB1*0401,  DRB1*0404 
ENPVVHFFKNIVTPR 2  DRB1*1501,  DRB5*0101 
ESKHGLTNTASHT   2  DRB1*0701,  DRB1*1501 
ESKHGLTNTASHTRLSCD 2  DRB1*0701,  DRB1*1501 
FDLEMLGDVESPS 2  DRB1*0401,  DRB1*0404 
FNNFTVSFWLRVPKVSASHLE 2  DRB1*1101,  DRB1*1104 
FPSKTSASIGSLCADARMYG 2  DRB1*0402,  DRB1*0401 
FYDCLKNSADTIS 2  DRB1*0401,  DRB1*0101 
GDYKTTICGKGLSATVTGGQ 2  DRB1*0402,  DRB1*0401 
GRHLIFCHSKRKCDELATKL 2  DRB1*1501,  DRB5*0101 
GSDTITLPCRIKQFINMWQE 2  DRB1*0402,  DRB1*0401 
GTEKLIETYFSKNYQDYEYL 2  DRB1*0402,  DRB1*0401 
HGLTNTASHTRLS 2  DRB1*0701,  DRB1*1501 
HTNVCFWYIPPSLRTLEDNE 2  DRB1*0301,  DRB1*0101 
KGFKGVDAQGTLSKI 2  DRB1*1501,  DRB5*0101 
KHGLTNTASHTRL   2  DRB1*0701,  DRB1*1501 
KHTDACCRTHDMCPDVMS 2  DRB1*0301,  DRB1*0701 
KNCSFNISTSIRGKV 2  DRB1*1101,  DRB1*0401 
LYGNEGMGWAGWLLA 2  DRB1*0401,  DRB1*1302 
NTWTTCQSIAFPSKTSASIG 2  DRB1*0402,  DRB1*0401 
PTDPRRRSRNLGKVA 2  DRB1*1101,  DRB1*1104 
QDVRFPGGGQIVGGA 2  DRB1*0102,  DRB1*0901 
QYIKANSAFIGITE   2  DRB1*1101,  DRB1*1302 
QYIKANSKFIGITEL   2  DRB1*0401,  DRB3*0101 
QYIKANSKFIGITELKKLE 2  DRB1*1101,  DRB1*1104 
RQPIPKARQPEGRA   2  DRB1*0701,  DRB1*1104 
SKHGLTNTASHTR 2  DRB1*0701,  DRB1*1501 
SLKPCVKLTPLCVSL 2  DRB1*1101,  DRB1*0401 
TASFWLRVPKVSSHLE 2  DRB1*1101,  DRB1*1104 
TKRNTLRRPQDVKFA 2  DRB1*0102,  DRB1*0402 
TVAFWLRVPKVSSHLE 2  DRB1*1101,  DRB1*1104 
TVSAWLRVPKVSSHLE 2  DRB1*1101,  DRB1*1104 
TVSFALRVPKVSSHLE 2  DRB1*1101,  DRB1*1104 
TVSFWLRVPKVASHLE 2  DRB1*1101,  DRB1*1104 
TVSFWLRVPKVSAHLE 2  DRB1*1101,  DRB1*1104 
TVSFWLRVPKVSASHLE 2  DRB1*1101,  DRB1*1104 
TVSFWLRVPKVSSALE 2  DRB1*1101,  DRB1*1104 
TVSFWLRVPKVSSHAE 2  DRB1*1101,  DRB1*1104 
TVSFWLRVPKVSSHLA 2  DRB1*1101,  DRB1*1104 
VAKVKIKPLEDKILV 2  DRB5*0101,  DRB1*1501 
VHFFKAIVTPRTP 2  DRB1*1302,  DRB1*0402 
VHFFKNIVAPRTP 2  DRB1*1501,  DRB1*1302 
VITQACPKVSFEPIP   2  DRB1*1101,  DRB1*0401 
VLLKEFTVSGNILTIRLT 2  DRB4*0101,  DRB4*0101 
VLPWNAFPGKVCGSNLLSIC 2  DRB1*0402,  DRB1*0401 
YDCLKNSADTISS   2 DRB1*0401,  DRB1*0101 
YPWPLYGNEGMGWA 2  DRB1*1302,  DRB1*1501 
YTTGAVRQIFGDYKTTICGK 2  DRB1*0402,  DRB1*0401 
 
Table 2: Grouping of DRB alleles using HERP stretch 
Group HERP  Stretch  Alleles 
number 
Alleles 
1 ESSECYDYNFDYWLQKRNYCHNVVF 17  DRB1*030101,  DRB1*030102, DRB1*030104, DRB1*030105, DRB1*030106, DRB1*0308, DRB1*0316, 






DRB1*110102, DRB1*110103, DRB1*110104, DRB1*110105, DRB1*110106, DRB1*110107, DRB1*1133, 
DRB1*1139, DRB1*1149, DRB1*1151, DRB1*1161, DRB1*1162, DRB1*1166, DRB1*131401, DRB1*131402, 
DRB1*131403 
3 WPRECFDYSFDYWIQAATYCHNVVF 12  DRB1*150102,  DRB1*150103, DRB1*150104, DRB1*150105, DRB1*150106, DRB1*1506, DRB1*1509, Bioinformation   open access 
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DRB1*110101, DRB1*110401, DRB1*110402, DRB1*1135, DRB1*1138, DRB1*1143, DRB1*1144, DRB1*1146, 
DRB1*1160, DRB1*1311 




















8  DRB1*070101, DRB1*070102, DRB1*0703, DRB1*0705, DRB1*0707, DRB1*0713, DRB1*0714, DRB1*0715 
11 ERSECYDYFYVSWLQKRNYCHNVGF 
 








7  DRB1*040101, DRB1*040102, DRB1*040103, DRB1*0416, DRB1*0426, DRB1*0433, DRB1*0463 
14 ESSECFDYYFDYWIDEATYCHNVVF 
 
7  DRB1*110201, DRB1*110202, DRB1*131403, DRB1*116501, DRB1*116502, DRB1*1322, DRB1*1352 
15 EACECNIYYYDYWLRRETYCYNVVF  7  DRB4*0102,  DRB4*01030101, DRB4*010302, DRB4*010303, DRB4*010304, DRB4*0106, DRB4*0107 
16 ESGECFDYYYSYWIDRLTYCHNVGF  6  DRB1*080302,  DRB1*0814, DRB1*0818, DRB1*0823, DRB1*0827, DRB1*0833 
17 ESSECFDYFYDYWLRRETYCHNVVF  6  DRB1*1117,  DRB1*140502, DRB1*140503, DRB1*142301, DRB1*142302, DRB1*1456 
18 ESSECFDYNFDYWIDEATYCHNVGF  6  DRB1*1120,  DRB1*130202, DRB1*130203, DRB1*1334, DRB1*1373, DRB1*1374 
19  ESSECFDYNFDYWFDRATYCHNVGF  5  DRB1*1109, DRB1*1128, DRB1*130502, DRB1*135001, DRB1*135002 
20 ESSECFDYFYAHWLRRETYCHNVVF  5  DRB1*140102, DRB1*140103, DRB1*1426, DRB1*1454, DRB1*1460 
21 WLFECLECSYDYWLQRATYCHNAVF  4  DRB1*010201, DRB1*010202, DRB1*010203, DRB1*010204 
22  EVHECFDYYYDYWLQRATYCHNVVF  4  DRB1*0404, DRB1*0423, DRB1*0432, DRB1*0440 
23 ESGECFDYYYSYWFDRLTYCHNVGF  4  DRB1*080101, DRB1*080102, DRB1*080103, DRB1*0826 
24  ESSECFDYFYDYWLRRETYCHNVGF  4  DRB1*1414, DRB1*1436, DRB1*144401, DRB1*144402 
25  QDYECFHDDYDYWFDRATYCHNVGF  4  DRB5*010101, DRB5*010102, DRB5*0105, DRB5*0113 
26  ESSECYDYNFDYWLQKRNYCHNVGF  3  DRB1*030501, DRB1*030502, DRB1*0309 
27 EVHECFDYSYDYWLQRETYCHNVVF  3  DRB1*040601, DRB1*040602, DRB1*0446 
28  EVHECFDYYYDYWLQRETYCHNVGF  3  DRB1*040701, DRB1*040702, DRB1*040703 
29  ESGECFDYYYDYWFDRLTYCHNVGF  3  DRB1*080201, DRB1*080202, DRB1*080203 
30  ESSECFDYYFDYWLDRATYCHNVGF  3  DRB1*110801, DRB1*110802, DRB1*1325 
31  ESSECFDYFFDYWFDRATYCHNVGF  3  DRB1*1110, DRB1*111201, DRB1*111202 
32  ESSECFDYYFDYWIDRATYCHNVGF  3  DRB1*111901, DRB1*111902, DRB1*1382 
33  ESSECFDYYYDYWFDRATYCHNVGF  3  DRB1*1137, DRB1*130701, DRB1*130702 
34 ESGECLEHLFVSWFDRATYCHNAVF  3  DRB1*120201, DRB1*120202, DRB1*1213 
35 ESGECLEHLFVSWIDRATYCHNAVF  3  DRB1*1206, DRB1*1207, DRB1*1210 
36  ESSECFDYFYAHWLRRATYCHNVVF  3  DRB1*140101, DRB1*143201, DRB1*143202 
37  WPRECFDYSYDYWFDRATYCHNVGF  3  DRB1*160101, DRB1*160102, DRB1*1603 
38  WPRECFDYSYDYWIDRATYCHNVGF  3  DRB1*160501, DRB1*160502, DRB1*1607 
39 ESSECFEYNYDYWLQKRNYCHNVGF  2  DRB1*030201,  DRB1*030202 
40 ESSECYDYNYDYWLQKRNYCHNVVF  2  DRB1*0306,  DRB1*0326 
41 EVHECFDYYYDYWLQRATYCHNVGF  2  DRB1*0408,  DRB1*0461 
42 EVHECFDYYYDYWFDRATYCHNVVF  2  DRB1*0415,  DRB1*0436 
43 ESGECFDYYYDYWFDRLTYCHNVVF  2  DRB1*080401,  DRB1*080402 
44 YTECYLRFVRAWNLRRVYCRNYVET  2  DRB1*080403,  DRB1*080404 
45 ESGECFDYFYDYWFDRLTYCHNVGF  2  DRB1*0809,  DRB1*0821 
46 ESGECFDYYFDYWFDRLTYCHNVVF  2  DRB1*0828,  DRB1*1167 
47 ESSECFDYYFDYWFDEATYCHNVVF  2  DRB1*1103,  DRB1*1324 
48 YTECHLRFVREWNLRRVYCRNYVET  2  DRB1*110403,  DRB1*110404 
49 ESSECFDYYFDYWFDRATYCHNAVF  2  DRB1*110601,  DRB1*110602 
50 ESSECFDYYFDYWFDEATYCHNVGF  2  DRB1*111101,  DRB1*111102 
51 ESSECFDYYFDYWIDEATYCHNVGF  2  DRB1*111401,  DRB1*1323 
52 ESSECFDYDFDYWFDRATYCHNVGF  2  DRB1*1124,  DRB1*1362 
53 ESSECFDYYFDYWFDRANYCHNVGF  2  DRB1*112701,  DRB1*112702 
54 ESSECFDYYFDYWLQRATYCHNVVF  2  DRB1*1134,  DRB1*1344 
55 ESSECFDYYYDYWIDEATYCHNVVF  2  DRB1*1148,  DRB1*1370 
56 ESSECFDYYYDYWFDRATYCHNVVF  2  DRB1*1150,  DRB1*1156 
57 ESSECFDYFYDHWLRRETYCHNVVF  2  DRB1*1152,  DRB1*1408 
58 ESSECFDYYFDYWFDRETYCHNVVF  2  DRB1*115401,  DRB1*115402 
59 ESSECFDYNFDYWFDRATYCHNVVF  2  DRB1*1158,  DRB1*1342 
60 ESGECLEHLFVSWIDRATYCHNVGF  2  DRB1*120101,  DRB1*120102 
61 ESGECLEHLFDYWIDRATYCHNAVF  2  DRB1*1204,  DRB1*1209 
62 ESGECLEHFFVSWIDRATYCHNAVF  2  DRB1*1205,  DRB1*1214 
63 ESSECFDYYYSYWIDKATYCHNVGF  2  DRB1*130301,  DRB1*130302 
64 ESSECFDYFYDYWIDEATYCHNVVF  2  DRB1*1308,  DRB1*1372 
65 ESSECYDYNFDYWIDEATYCHNVGF  2  DRB1*1327,  DRB1*1341 
66 ESSECFDYFFDYWIDEATYCHNVVF  2  DRB1*1364,  DRB1*1383 
67 ESSECFDYFYAHWLRRETYCHNVGF  2  DRB1*140701,  DRB1*140702 
68 WPRECFDYSFDYWFQAATYCHNVGF  2  DRB1*1504,  DRB1*1515 
69 ESSECFEYFYDYWLDRLTYCHNVGF  2  DRB1*1440,  DRB1*1477 
70 WPRECFDYSYDYWLDRATYCHNVGF  2  DRB1*160201,  DRB1*160202 
71 ELSECFEHNYDYWLQKQNYCHNVGF  2  DRB3*0206,  DRB3*0220 
72 ELSECFEHYYVSWLQKQNYCHNVGF  2  DRB3*0209,  DRB3*0221 
73 ELSECFEYFYVSWLQKQNYCHNVVF  2  DRB3*030101,  DRB3*030102 
 
Table 3: Validation of DRB alleles grouping using peptides with known overlapping function from MHCBN database 
Peptides HLA  DRB  alleles 
AVSFWLRVPKVSSHLE DRB1*1101,  DRB1*1104 
AYIKANSKFIGITE  DRB1*1101, DRB1*1104, DRB1*1302 
DGVNYATGNLPGCSA DRB1*1101,  DRB1*1104, DRB1*1301, DRB1*1302 Bioinformation   open access 
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DLMGYIPLVGAPLGA DRB1*1101,  DRB1*1104 
FNNFTVSFWLRVPKVSASHLE DRB1*1101,  DRB1*1104 
GAPLGGAARALAHGA  DRB1*1101, DRB1*1104, DRB1*1302 
GWLLSPRGSRPSWGA  DRB1*1101, DRB1*1104, DRB1*1302 
IDTLTCGFADLMGYA DRB1*1101,  DRB1*1104, DRB1*1301, DRB1*1302 
NLGKVIDTLTCGFA  DRB1*1101, DRB1*1104, DRB1*1301, DRB1*1302 
PTDPRRRSRNLGKVA DRB1*1101,  DRB1*1104 
QAIKANSKFIGITE  DRB1*1101, DRB1*1104, DRB1*1302 
QIVGGVYLLPRRGPA  DRB1*1101, DRB1*1104, DRB1*1301, DRB1*1302 
QYIKANSKFAGITE  DRB1*1101, DRB1*1104, DRB1*1302 
QYIKANSKFIAITE  DRB1*1101, DRB1*1104, DRB1*1302 
QYIKANSKFIGATE  DRB1*1101, DRB1*1104, DRB1*1302 
QYIKANSKFIGIAE  DRB1*1101, DRB1*1104, DRB1*1302 
QYIKANSKFIGITA  DRB1*1101, DRB1*1104, DRB1*1302 
QYIKANSKFIGITE  DRB1*1101, DRB1*1104, DRB1*1302 
QYIKANSKFIGITELKKLE DRB1*1101,  DRB1*1104 
RLGVRATRKTSERSA DRB1*1101,  DRB1*1104 
RRRSRNLGKVIDTLA DRB1*1101, DRB1*1104 
TASFWLRVPKVSSHLE DRB1*1101,  DRB1*1104 
TCGFADLMGYIPLVA  DRB1*1101, DRB1*1104, DRB1*1301, DRB1*1302 
TVAFWLRVPKVSSHLE DRB1*1101,  DRB1*1104 
TVSAWLRVPKVSSHLE DRB1*1101,  DRB1*1104 
TVSFALRVPKVSSHLE DRB1*1101,  DRB1*1104 
TVSFWLRVPKVASHLE DRB1*1101,  DRB1*1104 
TVSFWLRVPKVSAHLE DRB1*1101,  DRB1*1104 
TVSFWLRVPKVSASHLE DRB1*1101,  DRB1*1104 
TVSFWLRVPKVSSALE DRB1*1101,  DRB1*1104 
TVSFWLRVPKVSSHAE DRB1*1101,  DRB1*1104 
TVSFWLRVPKVSSHLA DRB1*1101,  DRB1*1104 
VYLLPRRGPRLGVRA  DRB1*1101, DRB1*1301, DRB1*1302 
  